Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. May’s top news stories
  2. Lack of CMO availability threatens cell and gene therapy development
  3. CD47-targeted therapies: the breast cancer mop?
  4. Through CRISPR gene editing we can change the nature of our species
  5. Could groundbreaking gene therapies offer a breakthrough to retinal disease sufferers?

Latest Content

June’s top news stories

AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the Phase III CASPIAN trial in first-line extensive-stage small cell lung cancer (SCLC).

Getting Acquainted with the Theory of XRF

This white paper provides a general introduction to X-ray Fluorescence (CRF) spectrometry and XRF analysis. It explains how a spectrometer works and how XRF analysis is achieved.

Mitochondrial Testing Services

Mitochondria are present in every cell of the body. They maintain cell homeostasis by controlling energy production, ion fluxes and the rate-limiting step of steroidogenesis.

May’s top news stories

Novartis reported that the first clinical trial in its Phase III PLATINUM programme for QMF149 has met primary and key secondary endpoints in people with inadequately controlled asthma; and The National Institute of Allergy and Infectious Diseases (NIAID) has reported findings from a Phase I/II clinical trial of Okairos’ AdCh3NSmut1/MVA-NSmut vaccine. Drugdevelopment-technology.com wraps up the key headlines from May 2019.

NIH supports genomic medicine trials for chronic diseases

The US National Institute of Health (NIH) has agreed to fund clinical trials investigating the practicality and effectiveness of using genomics data as part of treatments for chronic disease such as high blood pressure, depression and chronic pain.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top